| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 12 | +58.33% | -0.70% | -0.37% | -0.34% | -0.02% | — |
| 14d | 12 | +66.67% | -3.26% | -0.26% | -3.00% | -4.79% | — |
| 30d | 12 | +83.33% | -5.44% | +2.07% | -7.51% | -8.65% | — |
| 60d | 12 | +58.33% | -4.74% | +3.06% | -7.80% | -9.69% | — |
| 90d | 12 | +58.33% | -0.16% | +6.94% | -7.11% | -7.58% | — |
| 180d | 12(2 pending) | +60.00% | -3.08% | +14.55% | -17.63% | -20.15% | — |
| 1y | 12(2 pending) | +50.00% | +4.32% | +28.69% | -24.37% | -28.24% | — |
| 2y | 12(5 pending) | +71.43% | +2.41% | +29.77% | -27.36% | -46.54% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,700 | — | — | 2,700 | Jun 11, 2026 | Jun 15, 2026 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 34,901 | $50.00 | $1.75M | 952,317 | May 18, 2026 | May 19, 2026 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 40,892 | $51.10 | $2.09M | 987,218 | May 15, 2026 | May 19, 2026 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 52,018 | — | — | 1,028,110 | Feb 26, 2026 | Mar 2, 2026 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 30,617 | $43.67 | $1.34M | 976,092 | Feb 17, 2026 | Feb 18, 2026 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 35,870 | $43.92 | $1.58M | 1,006,709 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 34,278 | $43.00 | $1.47M | 1,042,579 | Feb 13, 2026 | Feb 18, 2026 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 40,459 | $45.23 | $1.83M | 1,076,857 | Jan 15, 2026 | Jan 16, 2026 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 149,474 | — | — | 1,117,316 | Jan 15, 2026 | Jan 16, 2026 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 21,810 | — | — | 21,810 | Jan 2, 2026 | Jan 21, 2026 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 27,000 | Jun 4, 2025 | Jun 6, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 100,000 | — | — | 0 | May 16, 2025 | May 16, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 100,000 | $18.80 | $1.88M | 1,067,842 | May 16, 2025 | May 16, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 100,000 | $46.00 | $4.60M | 967,842 | May 16, 2025 | May 16, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 41,422 | $44.65 | $1.85M | 967,842 | May 15, 2025 | May 16, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 170,009 | — | — | 1,009,264 | Mar 31, 2025 | Mar 31, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 59,648 | — | — | 839,255 | Feb 26, 2025 | Feb 28, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 29,314 | — | — | 100,000 | Feb 24, 2025 | Feb 26, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 29,314 | $36.14 | $1.06M | 779,607 | Feb 24, 2025 | Feb 26, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 29,314 | $18.80 | $551.1K | 808,921 | Feb 24, 2025 | Feb 26, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 21,591 | $35.00 | $755.7K | 779,607 | Feb 15, 2025 | Feb 19, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 132,973 | — | — | 837,147 | Jan 16, 2025 | Jan 17, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 35,949 | $37.27 | $1.34M | 801,198 | Jan 16, 2025 | Jan 17, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,274 | — | — | 35,274 | Jan 2, 2025 | Jan 8, 2025 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 17,506 | $35.05 | $613.6K | 704,174 | Nov 15, 2024 | Nov 19, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 125,000 | $27.19 | $3.40M | 721,680 | Aug 9, 2024 | Aug 9, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 125,000 | — | — | 0 | Aug 9, 2024 | Aug 9, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 125,000 | $24.41 | $3.05M | 846,680 | Aug 9, 2024 | Aug 9, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 27,000 | Jun 5, 2024 | Jun 7, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 10,211 | $20.99 | $214.3K | 733,158 | May 15, 2024 | May 17, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 8,621 | $20.99 | $181.0K | 743,369 | May 15, 2024 | May 17, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 11,478 | $20.99 | $240.9K | 721,680 | May 15, 2024 | May 17, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 82,121 | — | — | 751,990 | Feb 23, 2024 | Feb 27, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 80,186 | — | — | 691,731 | Jan 11, 2024 | Jan 16, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 21,862 | $22.86 | $499.8K | 669,869 | Jan 11, 2024 | Jan 16, 2024 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 65,135 | — | — | 628,692 | Sep 6, 2023 | Sep 8, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 17,147 | $22.27 | $381.9K | 611,545 | Sep 6, 2023 | Sep 8, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 8,074 | $21.51 | $173.7K | 563,557 | Aug 15, 2023 | Aug 17, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 60,000 | — | — | 0 | Aug 4, 2023 | Aug 7, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 60,000 | $20.68 | $1.24M | 571,631 | Aug 4, 2023 | Aug 7, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 60,000 | $14.74 | $884.4K | 631,631 | Aug 4, 2023 | Aug 7, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 60,000 | $14.74 | $884.4K | 631,631 | Aug 3, 2023 | Aug 7, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 60,000 | — | — | 60,000 | Aug 3, 2023 | Aug 7, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 60,000 | $20.51 | $1.23M | 571,631 | Aug 3, 2023 | Aug 7, 2023 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 27,000 | May 24, 2023 | May 25, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 10,002 | $19.18 | $191.8K | 571,631 | May 15, 2023 | May 17, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 8,444 | $19.18 | $162.0K | 581,633 | May 15, 2023 | May 17, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 85,414 | — | — | 590,077 | Apr 3, 2023 | Apr 5, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 5,278 | $18.08 | $95.4K | 504,663 | Feb 15, 2023 | Feb 17, 2023 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 8,074 | $16.71 | $134.9K | 509,941 | Nov 15, 2022 | Nov 17, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 225,000 | $6.21 | $1.40M | 670,882 | Aug 11, 2022 | Aug 12, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 225,000 | — | — | 0 | Aug 11, 2022 | Aug 12, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 152,867 | $19.23 | $2.94M | 518,015 | Aug 11, 2022 | Aug 12, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 8,074 | $21.49 | $173.5K | 445,882 | Aug 3, 2022 | Aug 5, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 32,567 | — | — | 453,956 | Aug 3, 2022 | Aug 5, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 8,444 | $20.08 | $169.6K | 421,389 | May 15, 2022 | May 17, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 75,985 | — | — | 429,833 | Mar 4, 2022 | Mar 8, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 15,626 | $18.59 | $290.5K | 353,848 | Feb 15, 2022 | Feb 17, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 2,701 | $18.59 | $50.2K | 369,474 | Feb 15, 2022 | Feb 17, 2022 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 19,491 | — | — | 377,306 | Dec 15, 2021 | Dec 17, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 5,131 | $17.00 | $87.2K | 372,175 | Dec 15, 2021 | Dec 17, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 8,227 | $18.10 | $148.9K | 407,301 | Nov 15, 2021 | Nov 17, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 46,920 | $18.10 | $849.3K | 357,815 | Nov 15, 2021 | Nov 17, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 2,566 | $18.10 | $46.4K | 404,735 | Nov 15, 2021 | Nov 17, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 32,567 | — | — | 424,101 | Sep 30, 2021 | Oct 4, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 8,573 | $20.63 | $176.9K | 415,528 | Sep 30, 2021 | Oct 4, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 90,000 | — | — | 0 | Sep 21, 2021 | Sep 23, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 90,000 | $3.66 | $329.4K | 446,591 | Sep 21, 2021 | Sep 23, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 55,057 | $20.33 | $1.12M | 391,534 | Sep 21, 2021 | Sep 23, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 64,150 | — | — | 356,591 | Mar 4, 2021 | Mar 5, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 4,105 | $21.91 | $89.9K | 292,441 | Feb 15, 2021 | Feb 17, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 9,745 | — | — | 255,341 | Feb 3, 2021 | Feb 5, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 59,411 | — | — | 314,752 | Feb 3, 2021 | Feb 5, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 18,206 | $22.56 | $410.7K | 296,546 | Feb 3, 2021 | Feb 5, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 30,000 | — | — | 90,000 | Jan 12, 2021 | Jan 14, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 30,000 | $25.00 | $750.0K | 245,596 | Jan 12, 2021 | Jan 14, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 30,000 | $3.66 | $109.8K | 275,596 | Jan 12, 2021 | Jan 14, 2021 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 2,633 | $20.16 | $53.1K | 245,596 | Nov 15, 2020 | Nov 17, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 8,227 | $20.16 | $165.9K | 248,229 | Nov 15, 2020 | Nov 17, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 2,737 | $20.16 | $55.2K | 256,456 | Nov 15, 2020 | Nov 17, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 178,231 | — | — | 306,113 | Oct 22, 2020 | Oct 26, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 46,920 | $21.79 | $1.02M | 259,193 | Oct 22, 2020 | Oct 26, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 10,000 | $3.66 | $36.6K | 137,882 | Oct 8, 2020 | Oct 9, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 10,000 | — | — | 120,000 | Oct 8, 2020 | Oct 9, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 10,000 | $25.00 | $250.0K | 127,882 | Oct 8, 2020 | Oct 9, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 20,000 | $3.66 | $73.2K | 147,882 | Sep 15, 2020 | Sep 15, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 20,000 | — | — | 130,000 | Sep 15, 2020 | Sep 15, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 20,000 | $25.00 | $500.0K | 127,882 | Sep 15, 2020 | Sep 15, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASEGRANT Stock grant | 9,745 | — | — | 130,448 | Sep 2, 2020 | Sep 4, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 2,566 | $21.58 | $55.4K | 127,882 | Sep 2, 2020 | Sep 4, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 78,583 | $25.81 | $2.03M | 120,703 | May 8, 2020 | May 8, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 78,583 | — | — | 150,000 | May 8, 2020 | May 8, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 78,583 | $3.66 | $287.6K | 199,286 | May 8, 2020 | May 8, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | PURCHASE EVP and CFO | 21,417 | $3.66 | $78.4K | 142,120 | May 7, 2020 | May 8, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 21,417 | — | — | 228,583 | May 7, 2020 | May 8, 2020 ↗ | View → |
| EXEL EXELIXIS, INC. | SALE EVP and CFO | 21,417 | $25.80 | $552.6K | 120,703 | May 7, 2020 | May 8, 2020 ↗ | View → |